Company / AR per Share
FATE THERAPEUTICS INC AR per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.01
FY2025
5-year range
$0.01 / $0.40
FY2021-FY2025
Trend
-77.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2025 to $0.40 in FY2022.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -35.6%.
Declined from $0.02 to $0.01 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- -72.9%
- 5-Year CAGR
- -35.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share decreased 77.6% year-over-year.
- Peak ar per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -77.6% |
| FY2024 | $0.04 | +91.2% |
| FY2023 | $0.02 | -95.3% |
| FY2022 | $0.40 | +306.4% |
| FY2021 | $0.10 | +35.8% |
| FY2020 | $0.07 | - |
| FY2019 | - | - |
| FY2018 | $0.01 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026